Fasting glucose 105
Searched over 200M research papers
Summary
5 papers analyzed
These studies suggest that a fasting glucose level of 105 may be influenced by genetic factors and is associated with an increased risk of type 2 diabetes and vascular diseases.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Fasting Glucose Levels and Their Implications
Fasting Glucose 105 mg/dL: An Overview
Fasting glucose levels are a critical marker for assessing metabolic health and the risk of developing diabetes. A fasting glucose level of 105 mg/dL is slightly above the normal range and can indicate impaired fasting glucose (IFG), a condition that is a precursor to type 2 diabetes.
Genetic Factors Influencing Fasting Glucose
Recent research has identified several genetic loci that influence fasting glucose levels. Variants in genes such as ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1, and C2CD4B have been associated with fasting glucose and beta-cell function, which are critical for insulin secretion and glucose regulation. Additionally, variants in the MTNR1B gene, which encodes the melatonin receptor, have been linked to higher fasting glucose levels and reduced beta-cell function, further increasing the risk of type 2 diabetes.
Impact of Gestational Diabetes on Fasting Glucose
Gestational diabetes mellitus (GDM) can significantly affect fasting glucose levels. Studies have shown that pregnant women with fasting glucose levels of 105 mg/dL or higher exhibit more pronounced metabolic abnormalities compared to those with lower fasting glucose levels. These abnormalities include higher premeal and postprandial glucose levels, elevated free fatty acids (FFA), and increased plasma triglycerides. These findings suggest that even a slight elevation in fasting glucose can have substantial metabolic consequences during pregnancy.
Dietary Interventions and Fasting Glucose
Fasting and energy-restricting diets have been shown to significantly reduce fasting blood sugar (FBS) levels. A meta-analysis of randomized controlled trials demonstrated that such diets lead to a decrease in FBS, insulin levels, and insulin resistance (HOMA-IR). These dietary interventions are particularly effective in overweight or obese individuals and when the treatment duration exceeds eight weeks.
Fasting Glucose and Vascular Disease Risk
Elevated fasting glucose levels are associated with an increased risk of vascular diseases, including coronary heart disease and stroke. A comprehensive meta-analysis revealed that diabetes doubles the risk of coronary heart disease and ischemic stroke, and even modest elevations in fasting glucose (between 5.60-6.99 mmol/L) are associated with a higher risk of coronary heart disease. This underscores the importance of maintaining fasting glucose within the normal range to mitigate vascular risk.
Conclusion
A fasting glucose level of 105 mg/dL, while only slightly elevated, can have significant implications for metabolic health and disease risk. Genetic factors, gestational diabetes, and dietary interventions all play crucial roles in influencing fasting glucose levels. Understanding these factors can help in the early identification and management of individuals at risk for diabetes and related vascular diseases.
Sources and full results
Most relevant research papers on this topic
